| Primary |
| Product Used For Unknown Indication |
30.6% |
| Gastrooesophageal Reflux Disease |
16.7% |
| Pain |
5.6% |
| Drug Therapy |
4.2% |
| Gastric Ulcer |
4.2% |
| Hiatus Hernia |
4.2% |
| Pneumonitis |
4.2% |
| Psoriatic Arthropathy |
4.2% |
| Unevaluable Event |
4.2% |
| Drug Use For Unknown Indication |
2.8% |
| Duodenal Ulcer |
2.8% |
| Reflux Gastritis |
2.8% |
| Spondylitis |
2.8% |
| Urinary Tract Infection |
2.8% |
| Abdominal Pain Upper |
1.4% |
| Affect Lability |
1.4% |
| Angina Unstable |
1.4% |
| Anticoagulant Therapy |
1.4% |
| Arthritis |
1.4% |
| Cardiomegaly |
1.4% |
|
| Clostridial Infection |
8.0% |
| Cutaneous Lupus Erythematosus |
8.0% |
| Rash Papulosquamous |
8.0% |
| Trismus |
8.0% |
| White Blood Cell Count Increased |
8.0% |
| Allodynia |
4.0% |
| Aspergillus Infection |
4.0% |
| Balance Disorder |
4.0% |
| Carcinoid Tumour Of The Stomach |
4.0% |
| Completed Suicide |
4.0% |
| Dermatitis Exfoliative |
4.0% |
| Diarrhoea |
4.0% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
4.0% |
| Eczema |
4.0% |
| Gastric Ulcer |
4.0% |
| Gastroenteritis |
4.0% |
| Hallucination, Visual |
4.0% |
| Hyperprolactinaemia |
4.0% |
| Hypokalaemia |
4.0% |
| Hyponatraemia |
4.0% |
|
| Secondary |
| Product Used For Unknown Indication |
57.6% |
| Gastroesophageal Reflux |
4.5% |
| Ischaemic Heart Disease Prophylaxis |
4.5% |
| Drug Use For Unknown Indication |
3.8% |
| Osteoporosis Prophylaxis |
3.8% |
| Hypertension |
3.0% |
| Dyslipidaemia |
2.3% |
| Functional Gastrointestinal Disorder |
2.3% |
| Type 2 Diabetes Mellitus |
2.3% |
| Diabetes Mellitus |
1.5% |
| Gastric Disorder |
1.5% |
| Gastrointestinal Motility Disorder |
1.5% |
| Liver Disorder |
1.5% |
| Malignant Glioma |
1.5% |
| Pemphigus |
1.5% |
| Peptic Ulcer |
1.5% |
| Salivary Hypersecretion |
1.5% |
| Schizophrenia |
1.5% |
| Ulcer |
1.5% |
| Analgesic Therapy |
0.8% |
|
| Colitis Microscopic |
14.7% |
| Trismus |
8.8% |
| Vitamin D Deficiency |
8.8% |
| Angioedema |
5.9% |
| Gastrointestinal Hypermotility |
5.9% |
| Tendonitis |
5.9% |
| White Blood Cell Count Decreased |
5.9% |
| White Blood Cell Count Increased |
5.9% |
| Wound Haemorrhage |
5.9% |
| Clostridium Difficile Infection |
2.9% |
| Hyperprolactinaemia |
2.9% |
| Hypomagnesaemia |
2.9% |
| Idiopathic Thrombocytopenic Purpura |
2.9% |
| Prurigo |
2.9% |
| Rash |
2.9% |
| Rash Generalised |
2.9% |
| Rash Maculo-papular |
2.9% |
| Scar |
2.9% |
| Therapeutic Response Decreased |
2.9% |
| Toxicity To Various Agents |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.0% |
| Hypertension |
10.0% |
| Depression |
7.6% |
| Plasma Cell Myeloma |
5.2% |
| Chronic Lymphocytic Leukaemia |
4.8% |
| Colorectal Cancer Metastatic |
3.6% |
| Osteoporosis |
3.6% |
| Headache |
3.2% |
| Neoplasm Malignant |
3.2% |
| Drug Use For Unknown Indication |
2.8% |
| Convulsion |
2.4% |
| Pain |
2.4% |
| Schizophrenia |
2.4% |
| Bone Marrow Failure |
2.0% |
| Breast Cancer |
2.0% |
| Lung Neoplasm Malignant |
2.0% |
| Prophylaxis |
2.0% |
| Affective Disorder |
1.6% |
| Epilepsy |
1.6% |
| Hepatic Fibrosis |
1.6% |
|
| Renal Failure Acute |
17.0% |
| Vomiting |
14.8% |
| White Blood Cell Count Decreased |
8.0% |
| Nausea |
5.7% |
| Weight Decreased |
5.7% |
| Muscular Weakness |
4.5% |
| Myalgia |
4.5% |
| Syncope |
4.5% |
| Dyspnoea |
3.4% |
| Pain |
3.4% |
| Pneumonia |
3.4% |
| Pulmonary Embolism |
3.4% |
| Pyrexia |
3.4% |
| Rash Pruritic |
3.4% |
| Tendonitis |
3.4% |
| Confusional State |
2.3% |
| Coombs Direct Test Positive |
2.3% |
| Femur Fracture |
2.3% |
| Haemorrhagic Stroke |
2.3% |
| Hypersensitivity |
2.3% |
|
